MSc, MHE, PhD
Health economist with more than 22 years of commercial experience in product reimbursement, technology assessment, market access and pricing. Prior to founding GMAS, Mark held pharmaceutical positions in Australia, and global positions in UK and Switzerland. Mark holds a guest lecturer position at the Pharmacoepidemiology and Pharmacoeconomics Department of the University of Groningen in the Netherlands. He has published over 80 peer-reviewed articles and has had his work reported in major print, television and internet media, including the BBC, Newsweek and the Economist.